Multiple fatalities involving a new designer drug: para-methyl-4-methylaminorex.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Analytical Toxicology

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/jat/bku031PMID 24830294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Monitoring Centre for Drugs and Drug Addiction

  2014cited by this paper
• Emerging drugs of abuse.

  2014cited by this paper
• The EMA has strengthened information sharing arrangements with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

  2012cited by this paper
• Emerging drugs of abuse.

  2005cited by this paper
• Spectral distinction between cis- and trans-4-methylaminorex

  1989cited by this paper
• The Stereoisomers of 4-Methylaminorex

  1989cited by this paper
• A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine.

  1988cited by this paper
• 2-AMINO-5-ARYL-2-OXAZOLINES. POTENT NEW ANORECTIC AGENTS.

  1963cited by this paper

• Worsening of the Toxic Effects of (±)Cis-4,4′-DMAR Following Its Co-Administration with (±)Trans-4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice

  2021cites this paper
• Designer drugs: mechanism of action and adverse effects

  2020cites this paper
• Aminorex analogs

  2019cites this paper
• New psychoactive substances: Popular and dangerous

  2018cites this paper
• DARK Classics in Chemical Neuroscience: Aminorex Analogues.

  2018cites this paper
• Neurochemical and Neuropharmacological Studies on a Range of Novel Psychoactive Substances

  2018cites this paper
• A validated, sensitive HPLC-MS/MS method for quantification of cis-para-methyl-4-methylaminorex (cis-4,4'-DMAR) in rat and human plasma: application to pharmacokinetic studies in rats.

  2017cites this paper
• Brain Disposition of cis-para-Methyl-4-Methylaminorex (cis-4,4′-DMAR) and Its Potential Metabolites after Acute and Chronic Treatment in Rats: Correlation with Central Behavioral Effects

  2017cites this paper
• Las nuevas drogas psicoactivas: populares y peligrosas

  2017cites this paper
• 4,4′‐Dimethylaminorex (“4,4′‐DMAR”; “Serotoni”) misuse: A Web‐based study

  2017influential citation
• “New Psychoactive Substances” (NPS)

  2016cites this paper
• United Kingdom drug situation: Focal Point annual report 2015.

  2016cites this paper
• 4‐Methyl‐5‐(4‐methylphenyl)‐4,5‐dihydrooxazol‐2‐amine (4,4′‐DMAR, 4,4′‐dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity

  2015cites this paper
• 4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse.

  2015cites this paper
• Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).

  2015cites this paper
• Post-mortem toxicology: A pilot study to evaluate the use of a Bayesian network to assess the likelihood of fatality.

  2015cites this paper
• Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').

  2014influential citation
• ACMDCouncil on the Misuse of Drugs

  2014cites this paper